Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Long Tang

Showing results (521-530 of 575) with videos related to

Pageof 58
Sort By:
Medicine|October 30, 2015
Prognostic Value and Grading of MRI-Based T Category in Patients With Nasopharyngeal Carcinoma Without Lymph Node Metastasis Undergoing Intensity-Modulated Radiation TherapyYu-Pei Chen, Ling-Long Tang, Wen-Na Zhang, et al.
Iscience|December 13, 2023
A tumor microenvironment-associated circRNA predictor for tumor relapse and chemotherapy vulnerability in nasopharyngeal carcinomaYe-Lin Liang, Yu-Heng Zhao, Cong Ding, et al.
Nano Letters|February 1, 2023
Atomic Insight into the Successive Antiferroelectric-Ferroelectric Phase Transition in Antiferroelectric OxidesRu-Jian Jiang, Yi Cao, Wan-Rong Geng, et al.
Cells|May 24, 2024
Correction: Zhao et al. Hypermethylation of UCHL1 Promotes Metastasis of Nasopharyngeal Carcinoma by Suppressing Degradation of Cortactin (CTTN). <i>Cells</i> 2020, <i>9</i>, 559Yin Zhao, Yuan Lei, Shi-Wei He, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 31, 2021
Identifying optimal clinical trial candidates for locoregionally advanced nasopharyngeal carcinoma: Analysis of 9468 real-world cases and validation by two phase 3 multicentre, randomised controlled trialSi-Qi Tang, Lei Chen, Wen-Fei Li, et al.
Cells|March 4, 2020
Hypermethylation of <i>UCHL1</i> Promotes Metastasis of Nasopharyngeal Carcinoma by Suppressing Degradation of Cortactin (CTTN)Yin Zhao, Yuan Lei, Shi-Wei He, et al.
International Journal of Surgery (London, England)|July 3, 2025
Comparative analysis of artificial intelligence tools for the dissemination of colorectal cancer screening guidelines: a novel perspective on early screening educationZheng Zhang, Zheng-Chao Zhang, Shu-Ping Zhang, et al.
Cell Death & Disease|February 6, 2024
Transcription factor ATMIN facilitates chemoresistance in nasopharyngeal carcinomaXue-Liang Fang, Qing-Jie Li, Jia-Yi Lin, et al.
International Journal of Radiation Oncology, Biology, Physics|May 13, 2022
Adjuvant Apatinib in Nasopharyngeal Carcinoma With Residual Epstein-Barr Virus DNA After Radiation Therapy: A Biomarker-Driven, Phase 2 TrialXu Liu, Ling Guo, Fang-Yun Xie, et al.
The Lancet. Oncology|March 3, 2022
Elective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: an open-label, non-inferiority, multicentre, randomised phase 3 trialLing-Long Tang, Cheng-Long Huang, Ning Zhang, et al.
Pageof 58

Showing results (521-530 of 575) with videos related to

Sort By:
Pageof 58
Medicine|October 30, 2015
Prognostic Value and Grading of MRI-Based T Category in Patients With Nasopharyngeal Carcinoma Without Lymph Node Metastasis Undergoing Intensity-Modulated Radiation TherapyYu-Pei Chen, Ling-Long Tang, Wen-Na Zhang, et al.
Iscience|December 13, 2023
A tumor microenvironment-associated circRNA predictor for tumor relapse and chemotherapy vulnerability in nasopharyngeal carcinomaYe-Lin Liang, Yu-Heng Zhao, Cong Ding, et al.
Nano Letters|February 1, 2023
Atomic Insight into the Successive Antiferroelectric-Ferroelectric Phase Transition in Antiferroelectric OxidesRu-Jian Jiang, Yi Cao, Wan-Rong Geng, et al.
Cells|May 24, 2024
Correction: Zhao et al. Hypermethylation of UCHL1 Promotes Metastasis of Nasopharyngeal Carcinoma by Suppressing Degradation of Cortactin (CTTN). <i>Cells</i> 2020, <i>9</i>, 559Yin Zhao, Yuan Lei, Shi-Wei He, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 31, 2021
Identifying optimal clinical trial candidates for locoregionally advanced nasopharyngeal carcinoma: Analysis of 9468 real-world cases and validation by two phase 3 multicentre, randomised controlled trialSi-Qi Tang, Lei Chen, Wen-Fei Li, et al.
Cells|March 4, 2020
Hypermethylation of <i>UCHL1</i> Promotes Metastasis of Nasopharyngeal Carcinoma by Suppressing Degradation of Cortactin (CTTN)Yin Zhao, Yuan Lei, Shi-Wei He, et al.
International Journal of Surgery (London, England)|July 3, 2025
Comparative analysis of artificial intelligence tools for the dissemination of colorectal cancer screening guidelines: a novel perspective on early screening educationZheng Zhang, Zheng-Chao Zhang, Shu-Ping Zhang, et al.
Cell Death & Disease|February 6, 2024
Transcription factor ATMIN facilitates chemoresistance in nasopharyngeal carcinomaXue-Liang Fang, Qing-Jie Li, Jia-Yi Lin, et al.
International Journal of Radiation Oncology, Biology, Physics|May 13, 2022
Adjuvant Apatinib in Nasopharyngeal Carcinoma With Residual Epstein-Barr Virus DNA After Radiation Therapy: A Biomarker-Driven, Phase 2 TrialXu Liu, Ling Guo, Fang-Yun Xie, et al.
The Lancet. Oncology|March 3, 2022
Elective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: an open-label, non-inferiority, multicentre, randomised phase 3 trialLing-Long Tang, Cheng-Long Huang, Ning Zhang, et al.
Pageof 58